Nanobiotix S.A. (NANO.PA)
EUR 3.48
(1.93%)
EUR 3.48
(1.93%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 200 Thousand EUR | 100.0% |
| 2022 | 100 Thousand EUR | 0.0% |
| 2021 | - EUR | 0.0% |
| 2020 | - EUR | 0.0% |
| 2019 | - EUR | 0.0% |
| 2018 | - EUR | -100.0% |
| 2017 | 1.00 EUR | 0.0% |
| 2016 | 1.00 EUR | 0.0% |
| 2015 | - EUR | 0.0% |
| 2014 | - EUR | -100.0% |
| 2013 | 199.54 Thousand EUR | 118.63% |
| 2012 | -1.07 Million EUR | -1319.66% |
| 2011 | 87.8 Thousand EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 2.26 Million EUR | 0.0% |
| 2023 FY | 200 Thousand EUR | 100.0% |
| 2023 Q4 | 200 Thousand EUR | 0.0% |
| 2023 Q2 | 1.00 EUR | 0.0% |
| 2022 Q2 | 1.00 EUR | 0.0% |
| 2022 FY | 100 Thousand EUR | 0.0% |
| 2022 Q4 | 100 Thousand EUR | 0.0% |
| 2021 Q2 | - EUR | 0.0% |
| 2021 FY | - EUR | 0.0% |
| 2021 Q4 | - EUR | 0.0% |
| 2020 Q2 | 1.00 EUR | 0.0% |
| 2020 FY | - EUR | 0.0% |
| 2020 Q4 | - EUR | 0.0% |
| 2019 Q2 | 1.00 EUR | 0.0% |
| 2019 FY | - EUR | 0.0% |
| 2019 Q4 | - EUR | 0.0% |
| 2018 FY | - EUR | -100.0% |
| 2018 Q2 | - EUR | 0.0% |
| 2018 Q4 | - EUR | 0.0% |
| 2017 FY | 1.00 EUR | 0.0% |
| 2017 Q4 | 1.00 EUR | 0.0% |
| 2017 Q2 | - EUR | 0.0% |
| 2016 Q2 | - EUR | 0.0% |
| 2016 FY | 1.00 EUR | 0.0% |
| 2016 Q4 | 1.00 EUR | 0.0% |
| 2015 FY | - EUR | 0.0% |
| 2015 Q4 | - EUR | 0.0% |
| 2015 Q2 | - EUR | 0.0% |
| 2014 Q4 | - EUR | 0.0% |
| 2014 Q2 | - EUR | 0.0% |
| 2014 FY | - EUR | -100.0% |
| 2013 Q4 | 199.54 Thousand EUR | 0.0% |
| 2013 Q2 | 1.00 EUR | 0.0% |
| 2013 FY | 199.54 Thousand EUR | 118.63% |
| 2012 FY | -1.07 Million EUR | -1319.66% |
| 2012 Q4 | -1.07 Million EUR | 0.0% |
| 2011 FY | 87.8 Thousand EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| ABIONYX Pharma SA | 221 Thousand EUR | 9.502% |
| ABIVAX Société Anonyme | 1.00 EUR | -19999900.0% |
| Adocia SA | 272 Thousand EUR | 26.471% |
| Aelis Farma SA | 53 Thousand EUR | -277.358% |
| Biophytis S.A. | - EUR | -Infinity% |
| Advicenne S.A. | 1.74 Million EUR | 88.512% |
| genOway Société anonyme | 982.75 Thousand EUR | 79.649% |
| IntegraGen SA | 311.44 Thousand EUR | 35.784% |
| Medesis Pharma S.A. | 164.62 Thousand EUR | -21.49% |
| Neovacs S.A. | - EUR | -Infinity% |
| NFL Biosciences SA | -1.1 Million EUR | 118.04% |
| Plant Advanced Technologies SA | 1.22 Million EUR | 83.668% |
| Quantum Genomics Société Anonyme | -119.17 Thousand EUR | 267.819% |
| Sensorion SA | - EUR | -Infinity% |
| Theranexus Société Anonyme | - EUR | -Infinity% |
| TME Pharma N.V. | 91 Thousand EUR | -119.78% |
| Valbiotis SA | 1 Million EUR | 80.099% |
| TheraVet SA | 123.34 Thousand EUR | -62.151% |
| Valerio Therapeutics Société anonyme | 1.00 EUR | -19999900.0% |
| argenx SE | 281.12 Million EUR | 99.929% |
| BioSenic S.A. | - EUR | -Infinity% |
| Celyad Oncology SA | 1.26 Million EUR | 84.127% |
| DBV Technologies S.A. | 1.00 USD | -19999900.0% |
| Galapagos NV | 73.97 Million EUR | 99.73% |
| Genfit S.A. | 4000.00 EUR | -4900.0% |
| GeNeuro SA | - EUR | -Infinity% |
| Hyloris Pharmaceuticals SA | 1.00 EUR | -19999900.0% |
| Innate Pharma S.A. | 1.00 EUR | -19999900.0% |
| Inventiva S.A. | 417 Thousand EUR | 52.038% |
| MaaT Pharma SA | 190 Thousand EUR | -5.263% |
| MedinCell S.A. | -6.71 Million EUR | 102.979% |
| Onward Medical N.V. | 936 Thousand EUR | 78.632% |
| Oryzon Genomics S.A. | 6029.00 EUR | -3217.3% |
| OSE Immunotherapeutics SA | - EUR | -Infinity% |
| Oxurion NV | 128 Thousand EUR | -56.25% |
| Pharming Group N.V. | 51.38 Million EUR | 99.611% |
| Poxel S.A. | 2.95 Million EUR | 93.234% |
| GenSight Biologics S.A. | 1.00 EUR | -19999900.0% |
| Transgene SA | - EUR | -Infinity% |
| Financière de Tubize SA | - EUR | -Infinity% |
| UCB SA | 1.03 Billion EUR | 99.981% |
| Valneva SE | 44.46 Million EUR | 99.55% |
| Vivoryon Therapeutics N.V. | 1.00 EUR | -19999900.0% |